3 results about "Isoliquiritigenin" patented technology

A small molecule composition, comprising licochalcone A, licochalcone C, licochalcone D, licochalcone E, echinatin, isoliquiritigenin, formononetin, liquiritigenin, licoflavone C, glabrol, licoisoflavone A and licoisoflavone B, and the use thereof in preparing anticancer or antitumor drugs, anti-ferroptosis drugs, or drugs for sensitization of anticancer or antitumor drugs. The small molecule composition can also be used in combination with other antitumor drugs.

The application discloses a kind of based on isoliquiritigenin biological base temperature-resistant antibacterial foam cotton material and preparation method and application thereof, the foam cotton material is obtained by foaming based on the main chain type benzoxazine resin of isoliquiritigenin biological base, with maleic anhydride, foaming agent master batch, the main chain type benzoxazine resin of based on isoliquiritigenin biological base molecular formula as shown below.The application is prepared with the main chain type benzoxazine resin of isoliquiritigenin biological base as organism to obtain the benzoxazine foam with temperature-resistant antibacterial property of body.The foam cotton material of the application has the following advantages: based on the molecular structure of isoliquiritigenin, product has excellent antibacterial property;High crosslinking density benzoxazine gives product excellent temperature resistance;The product thermal conductivity is as low as 0.033W / (m·K), and the product has wide application in medical equipment, electronic equipment, new energy automobile and other fields.

This invention belongs to the field of biomedical technology, specifically relating to an isoliquiritigenin composition for improving depression and its preparation method. The isoliquiritigenin composition for improving depression comprises the following raw materials in parts by weight: 22-40 parts isoliquiritigenin, 10-17 parts N-acetyl-D-glucosamine, and 15-20 parts β-lapaquinone. Isoliquiritigenin, N-acetyl-D-glucosamine, and β-lapaquinone constitute a multi-target synergistic isoliquiritigenin composition for improving depression. Experimental results show that by taking the isoliquiritigenin composition prepared according to this invention, it can systematically exert its effects and comprehensively improve the pathological state of depression, showing broad application prospects.